Sulfate is important for mammalian growth and development. During pregnancy, maternal circulating sulfate levels increase by 2-fold, enhancing sulfate availability to the fetus. We used quantitative real-time PCR to determine sulfate transporter mRNA levels during mouse gestation in three tissues: kidney and ileum, to identify transporters involved in sulfate absorption and maintaining high maternal circulating sulfate level; and placenta, to build a model of directional sulfate transport from mother to fetus. In the kidney, Slc13a1 and Slc26a1 were the most abundant sulfate transporter mRNAs, which increased by '2-fold at E4.5 or E6.5, whereas lower levels of Slc26a2, Slc26a6, and Slc26a7 mRNA increased by '3-to 6-fold from E4.5. Ileal sulfate transporter mRNA levels were not increased in gestation, but slight decreases (by '30-40%) were found for Slc26a3 and Slc26a6. In placentae, Slc13a4 and Slc26a2 mRNAs were most abundant, with levels increasing from E10.5 and peaking ('8-fold) from E14.5 to E18.5, whereas Slc26a1 increased by '3-fold at E18.5. The spatial expression of placental mRNAs was determined by in situ hybridization showing Slc13a4 and Slc26a6 in yolk sac, Slc26a1 in spongiotrophoblasts, and Slc13a4, Slc26a2, Slc26a3, and Slc26a7 in the labyrinthine layer. Within the labyrinth, cell-specific staining revealed Slc13a4 expression in syncytiotrophoblast-II (SynT-II) and Slc26a2 in SynT-I. Together, these data show kidney Slc13a1 and Slc26a1 and placental Slc13a4 and Slc26a2 to be the most abundant sulfate transporter mRNAs in mouse gestation, which likely play important physiological roles in maintaining high maternal serum sulfate levels during pregnancy and mediating sulfate supply to the fetus. placental transport, pregnancy, sulfate transporter
INTRODUCTION
Sulfate is an obligate nutrient for fetal growth and development [1] . Numerous cellular and metabolic processes are regulated by sulfate conjugation (sulfonation) of iodothyronines [2, 3] , steroids [4] , catecholamines [5] , and glycosaminoglycans [6, 7] . Sulfate also contributes to the detoxification of xenobiotics and certain pharmacological drugs, including acetaminophen [8] . A sufficient supply of sulfate and its universal sulfonate donor, 3
0 -phosphoadenosine 5 0 -phosphosulfate (PAPS), are required for sulfonation reactions to function effectively. In humans, impaired sulfonation has been reported in developmental dwarfism [9] , skeletal dysplasias [10, 11] , premature pubarche [12] , and reduced acetaminophen metabolism [13] . In addition, reduced sulfate supply [14, 15] or estrogen sulfonation capacity [16] has been linked to midgestational fetal loss in mice, indicating an important role of sulfate in maintaining pregnancy.
During human and rodent pregnancy, maternal circulating sulfate levels increase by approximately 2-fold: levels peak from mid-to late gestation, when high sulfate levels are required for fetal development [1, 15, 17] . This increase in maternal sulfate level is remarkable because most circulating analytes decrease slightly in pregnancy due to hemodilution [18] , indicating that high plasma sulfate levels are likely to play an important role in enhancing sulfate availability to the growing fetus in both human and animal gestation. In pregnant women, increased plasma sulfate levels are correlated with elevated renal sulfate reabsorption [19] , which is mediated by the NaS1 and SAT1 sulfate transporters [20] . NaS1 is expressed on the apical brush border membrane of the kidney proximal tubule, where it mediates the first step of sulfate reabsorption, while SAT1, located on the basolateral membrane, mediates the second step. Both NaS1 (SLC13A1) and Sat1 (SLC26A1) genes are also expressed in the intestine, where they effect sulfate absorption [14, 21] . However, the relative contributions of kidney and intestinal NaS1 and Sat1 to maintaining high maternal sulfate levels in pregnancy have yet to be studied. NaS1 and Sat1 null mice exhibit renal sulfate wasting and hyposulfatemia [14, 21] . Recently, we showed that maternal hyposulfatemia in pregnant NaS1 null mice led to fetal hyposulfatemia, perturbed placental morphology, and midgestational fetal loss [15] . Together, these findings demonstrate the importance of maternal kidney sulfate transporters in maintaining high circulating sulfate levels in pregnancy.
Dietary sulfate and metabolism of sulfur-containing amino acids contribute to intracellular sulfate requirements in children and adults. However, the developing fetus has negligible capacity to generate sulfate from methionine and cysteine [22, 23] and relies on sulfate to be supplied from maternal circulation via placental sulfate transporters. To date, 10 human and rodent sulfate transporters have been identified belonging to the solute linked carrier (SLC) 13 and SLC26 gene families [24] . While NaS2 (SLC13A4), SLC26A2, SLC26A7, and SLC26A11 mRNAs have been detected in the placenta at late gestation [24] [25] [26] [27] , the temporal and spatial expression of these and other sulfate transporter mRNAs at earlier gestational ages has not been reported. To build a model of directional sulfate transport in the placenta, we investigated the relative abundance, temporal profile, and spatial expression of the 10 known sulfate transporter mRNAs in mouse placenta from gestational ages E6.5 to E18.5. In addition, to determine the involvement of intestinal and renal sulfate transporter gene expression to increased sulfatemia in pregnancy, we measured the relative abundance of maternal ileum and kidney sulfate transporter mRNAs from early (E4.5) to late (E18.5) mouse gestation.
MATERIALS AND METHODS

Animals
Male and virgin female CD1 mice were housed together overnight; the presence of a copulatory plug the following morning indicated successful mating and was designated Embryonic Day 0.5 (E0.5). Pregnant female mice were singly housed in conventional conditions and fed a standard rodent chow containing the sulfate minerals, potassium sulfate (46.60 mg/kg), and chromium potassium sulfate (0.275 mg/kg) as well as the sulfur-containing amino acid L-cystine (3000 g/kg; no. AIN93G; Glen Forrest Stockfeeders) [28] and water ad libitum. Females were randomly selected on E4.5, E6.5, E8.5, E10.5, E12.5, E14.5, and E18.5 of pregnancy to be euthanized for analysis of ileal, renal, or placental tissues. For some experiments, animals were ovariectomized as previously described [29] and allowed to rest for 5 days, then randomly assigned to treatment groups and injected with either 100 ng Bestradiol (E 2 ; Sigma E8875), 1 mg progesterone (P 4 ; Sigma P0130), 100ng E 2 þ 1 mg P 4 , or sesame oil alone (control) subcutaneously once per day for 3 days. The day following the last injection, animals were euthanized and tissues collected for RNA isolation. All procedures were reviewed by and received the approval of the University of Queensland Animal Ethics Office.
Quantitative Real-Time PCR Analysis of Gene Expression
Total RNA was isolated from the ileum, kidneys, and placentae of female mice using previously described methods [14] . We examined the mRNA levels of 10 sulfate transporter genes (Table 1) as well as a placental transcription factor (glial cell missing 1 [Gcm1]) gene that we included as a control for its established temporal expression profile starting at E7.5 and peaking in late gestation [30] . Total RNA (4 lg) was reverse transcribed by using random hexamers and an Omniscript RT kit (Qiagen) as recommended by the manufacturer. PCR was performed in quadruplicate on each of three independent samples from individual animals, with 5ll cDNA (from 25 ng RNA) and 10 ll mastermix containing SYBR Green Master Mix (Roche) and 200 nM forward and reverse primers (Table 1 ) in a Rotor-Gene 6000 thermal cycler (Corbett Research). The thermal cycling protocol was 508C for 2 min, 948C for 2 min, 45 cycles of 948C for 1 sec, 608C for 10 sec, and 728C for 15 sec. RNA expression levels and absolute threshold cycle values (Ct values) of each gene were normalized to those of 18S ribosomal RNA with the RotorGene 6000 series software (Corbett Research). Amplification specificity was confirmed by melting curve analysis and agarose gel electrophoresis.
In Situ Hybridization
Synthesis of digoxigenin (DIG)-labeled probes was performed according to the manufacturer's instructions (Roche; DIG RNA Labeling Mix, Cat. No. 11277073910) using PCR-amplified cDNA templates generated with genespecific primers (Table 2 ). Tissues to be used for in situ hybridization were dissected into 4% paraformaldehyde in PBS and fixed overnight at 48C. Samples were processed, embedded in paraffin, sectioned at 7 lm, and probed with sulfate transporter-specific riboprobes as previously described [31] with some modifications. Briefly, paraffin sections were dewaxed and rehydrated to PBS under RNase-free conditions, treated with 30 ug/ml proteinase K (Roche) in 50 mM Tris/2.5 mM EDTA for 20 min at room temperature, acetylated with 0.25% acetic anhydride (Sigma) in 0.1 M triethanolamine (Sigma) buffer for 10 min, and hybridized with ;50 ng of DIG-labeled riboprobe/section in 200 ul hybridization buffer; 13 salts (200 mM sodium chloride, 13 mM tris, 5 mM sodium phosphate monobasic, 5 mM sodium phosphate dibasic, 5 mM EDTA), 50% formamide, 10% dextransulfate, 1 mg/ml yeast tRNA (Roche), and 13 Denhardt's (1% w/v bovine serum albumin, 1% w/v Ficoll, 1% w/v polyvinylpyrrolidone) at 658C overnight. Posthybridization washes, antibody detection of DIG-labeled probes, and color development were all performed as previously described [31] . Isolectin B4 (Sigma) staining, following in situ hybridization, was performed as previously described [32] . For double-labeled in situ hybridizations, cryo-embedded samples were used as previously described [31] ; differently from paraffin sections, cryo-sections were cut to 10 lm and treated with only 15 lg proteinase K for 5 min. For the second gene, fluorescein-labeled RNA probes were used, synthesized according to the same procedure (Roche; Fluorescein RNA Labeling Mix, Cat. No. 11685619910) and detected using an alkaline phosphatase conjugated antifluorescein antibody together with INT/BCIP (Roche).
Western Immunoblotting
Placental homogenates from E8.5 (mixed pool of three placentae per group, n ¼ 2 groups) and E12.5, E14.5, and E18.5 (n ¼ 3 individual placentae) pregnant mice, containing 13 lg of protein, were separated on a 12% SDS polyacrylamide gel and transferred to PVDF membranes (Invitrogen). Immunoreactive proteins were detected with SLC13A4 polyclonal antibody (Proteintech Group Inc.) and mouse b-actin monoclonal antibody (Novus Biologicals) with IRDye CW800-labeled anti-rabbit (for SLC13A4) or CW700-labeled anti-mouse (for b-actin) IgG using the Odyssey Imaging System (LI-COR Biotechnology).
Statistical Analysis
The statistical significance of the differences of mRNA levels with their respective controls (sesame oil-treated controls, nonpregnant mice, or at E6.5 gestational age) was evaluated using a one-way ANOVA, followed by a Dunnett multiple comparisons test, with P , 0.05 considered significant.
RESULTS
Kidney and Ileum Sulfate Transporter mRNA Expression in Mouse Gestation
In the ileum, Slc13a4, Slc26a7, Slc26a8, and Slc26a9 mRNAs were not detected in nonpregnant mice or at any stage of mouse gestation (data not shown), whereas Slc13a1 and Slc26a2 were the most abundant transcripts at all gestational ages, compared to lower mRNA levels of Slc26a3, Slc26a6, Slc26a1, and Slc26a11 (Supplemental Figure S1 ; all Supplemental Data are available online at www.biolreprod.org). There were no significant changes in ileal Slc13a1, Slc26a1, Slc26a2, and Slc26a11 mRNA levels throughout mouse gestation, whereas decreased mRNA levels of Slc26a3 (by '30-40%) and Slc26a6 (by '40%) were measured in ileum from pregnant mice when compared to nonpregnant mice (Supplemental Figure S1 ). 
In the kidneys, Slc13a1 was the most abundant sulfate transporter mRNA, which increased by '2-fold at E4.5 and E6.5, and then returned to levels that were similar to nonpregnant mice from E8.5 ( Fig. 1) . Kidney Slc26a1 mRNA levels increased by '2-fold at E6.5 but returned to levels found in nonpregnant mice from E8.5. Slc26a2, Slc26a6, and Slc26a7 mRNA levels increased by '3-to 6-fold from E4.5, whereas Slc26a11 mRNA levels remained constant throughout gestation and were similar to nonpregnant mice. Slc13a4, Slc26a3, Slc26a8, and Slc26a9 mRNAs were not detected in nonpregnant mice or in maternal kidneys at any stages of gestation (data not shown).
Kidney and Ileum Sulfate Transporter mRNA Expression in Estrogen-and Progesterone-Treated Mice
To determine the involvement of estrogen (E 2 ) and progesterone (P 4 ) in regulating kidney sulfate transporter mRNA levels in pregnant female mice, we treated ovariectomized mice with E 2 and/or P 4 for 3 days and compared the abundance of kidney mRNAs to vehicle-treated mice. Slc13a1, Slc26a2, Slc26a6, Slc26a7, and Slc26a11 mRNA levels were similar in E 2 -, P 4 -, and E 2 þ P 4 -treated mice when compared to vehicle-treated mice, whereas Slc26a1 mRNA levels were increased slightly by '1.5-fold in E 2 þ P 4 -treated mice, but no significant change was observed when E 2 or P 4 were administered individually (data not shown).
Placental Sulfate Transporter mRNA Expression in Mouse Gestation
Slc13a4 and Slc26a2 were the most abundant mRNAs, with levels increasing from E10.5 and peaking from E14.5 to E18.5 (Fig. 2) . Slc26a1 mRNA levels increased by '3-fold at E18.5, whereas Slc26a11 and Slc26a6 mRNAs remained at constant levels throughout gestation (data not shown). Slc26a7 mRNA levels were negligible from E6.5 to E10.5 but then increased by '4-fold by E18.5 (Fig. 2) . Slc13a1, Slc26a3, Slc26a8, and Slc26a9 mRNA levels were negligible throughout mouse gestation, although Slc26a3 was briefly expressed at low levels at E6.5 and E14.5 (data not shown). As a control for our quantitative real-time PCR analyses, we determined the placental mRNA levels of Gcm1, which is a transcription factor expressed in chorion from E7.5, and later in labyrinthine syncytiotrophoblasts [33] . In this study, Gcm1 mRNA levels in placental samples followed the previously established temporal expression profile, with levels peaking at E14.5 (Supplemental Figure S2 ).
Placental SLC13A4 Protein Expression in Mouse Gestation
To confirm that the placental mRNA profile correlates with changes in protein levels, we used Western blot analyses to compare the abundance of SLC13A4 protein from E8.5 to E18.5 gestational ages. SLC13A4 was selected because it was found to be the most up-regulated sulfate transporter mRNA in mouse gestation (Fig. 2) . Low levels of SLC13A4 protein were detected at gestational ages E8.5 and E12.5, whereas increased levels were detected at E14.5 (by '2-fold) and E18.5 (by '4-fold) when compared to E8.5 (Fig. 3) , thus complementing the Slc13a4 mRNA profile in mouse placenta.
Spatial Expression of Placental Sulfate Transporters
In order to determine the spatial localization of those sulfate transporters expressed by the developing placenta, we performed in situ hybridization on placental sections from E7.5 to E18.5. We did not attempt in situ hybridization for Slc26a8, Slc26a9, or Slc13a1, as their expression levels in placenta were essentially undetectable by quantitative real-time PCR. We found two sulfate transporters, Slc13a4 and Slc26a6, to be expressed in the yolk sac early in gestation, with Slc13a4 highly expressed, while Slc26a6 is expressed at lower levels (Fig. 4A ). Slc26a1 expression is restricted largely to the spongiotrophoblast layer (Fig. 4B) . At least four sulfate transporters are expressed in the labyrinthine layer during gestation: Slc13a4 and Slc26a2 are the most abundant labyrinthine sulfate transporters, while Slc26a7 is not detectable until E14.5, and Slc26a3 is detectable at low levels only at E6.5 and E14.5 (Fig. 4B) . While expressed at significant levels throughout placental development, we were not able to detect Slc26a11 expression by in situ hybridization despite multiple attempts with three independent probe sets. We therefore cannot determine the cell type expressing Slc26a11 during mouse gestation at this time.
The labyrinthine layer of the placenta contains a tortuous network of small maternal blood sinusoids intimately intercalated with fetal capillaries and is the site of nutrient and waste exchange during pregnancy. Separating the maternal and fetal 
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blood spaces is a highly organized cellular barrier, which in rodents consists of a trilaminar trophoblast layer, made up of one layer of mononuclear sinusoidal trophoblast giant cells (S-TGC), two layers of syncytiotrophoblasts (SynT-I and SynT-II), and a layer of fetal endothelial cells (Fig. 6) . To maximize the efficiency of transport during gestation, the barrier becomes very thin, making it very difficult to discern the precise cell types responsible for positive gene expression by in situ hybridization experiments with colormetric detection and standard imaging techniques. Therefore, we utilized cellspecific gene markers and double staining procedures to further elucidate the labyrinthine cell types expressing Slc13a4 and Slc26a2 throughout gestation (Fig. 5, A and B) . Slc13a4 and Slc26a2 in situ hybridizations were initially performed in conjunction with isolectin B4 staining, which can be used to visualize the extracellular matrix surrounding fetal vessels [32] (Fig. 5, C and D) . Slc13a4 and Slc26a2 blue staining (Fig. 5, C and D, respectively) can be seen on the side of the matrix closest to the maternal blood spaces rather than on the side of the fetal vessels, indicating a trophoblast cell origin of expression rather than fetal endothelial cells. Neither Slc13a4 nor Slc26a2 mRNAs were detected in S-TGCs (Fig. 5, C-F; data not shown). Double in situ hybridization experiments revealed that Slc13a4 expression does not appear to overlap with that of SynA, a marker of SynT-I cells [30] , in E14.5 placentae (Fig. 5E ), suggesting that Slc13a4 expression is restricted to SynT-II cells. Furthermore, in situ hybridizations on serial sections demonstrated Slc13a4 to be expressed in the same pattern as Gcm1 earlier in development, within clusters of cells along the leading edge of the chorion destined to become SynT-II cells (Fig. 5, G and H) . In contrast, expression of Slc26a2, which appears to be trophoblast in origin (Fig. 5D ), is not expressed by S-TGCs and does not colocalize with Slc13a4 mRNA, indicating SynT-I cell-specific expression (Fig. 5F ).
DISCUSSION
In this study, we investigated the relative abundance and temporal profile of maternal kidney and ileal sulfate transporter gene expression in pregnant wild-type mice at six time points after conception. E4.5 was chosen as the earliest time point because this gestational age is well before the peak in maternal serum sulfate levels at E12.5 [15] . We show that ileal Slc13a1, Slc26a1, Slc26a2, and Slc26a11 mRNA levels are similar in pregnant and nonpregnant mice as well as slightly decreased ileal Slc26a3 and Slc26a6 mRNA levels during gestation. In contrast, we show elevated levels of several sulfate transporters in kidney during pregnancy. . Median, range, and P-values (*P , 0.05, **P , 0.01, and ***P , 0.001) from a multiple comparisons test.
DAWSON ET AL.
In the kidneys, sulfate is filtered in the glomerulus and then reabsorbed through epithelial cells in the proximal tubule: first across the apical membrane, where Slc13a1, Slc26a2, and Slc26a6 are expressed, and then via Slc26a1 on the basolateral membrane [34] [35] [36] [37] . Slc26a7 is expressed in intercalated cells of collecting ducts, where it exchanges anions, including sulfate [37, 38] . In the present study, we found that pregnant mice have markedly increased kidney Slc13a1, Slc26a1, Slc26a2, Slc26a6, and Slc26a7 mRNA levels from early gestation. Both Slc13a1 and Slc26a1 null mice exhibit hypersulfaturia and hyposulfatemia [14, 21] , demonstrating that Slc26a2, Slc26a6, and Slc26a7 do not compensate for loss of Slc13a1 and Slc26a1. Together, these data indicate that increased kidney Slc13a1 (at E4.5 and E6.5) and Slc26a1 (at E6.5) mRNA levels may be important for effectuating high maternal sulfatemia during pregnancy.
Surprisingly, pregnancy-dependent increases in renal sulfate transporter mRNA levels are evident very early in gestation (by E4.5), suggesting regulation by the ovarian hormones rather than by embryonal-or placental-derived endocrine signals. To investigate this possibility, ovariectomized mice were treated with E 2 alone, P 4 alone, E 2 þ P 4 , or vehicle for 3 days and renal mRNA expression levels analyzed by quantitative realtime PCR. Neither E 2 nor P 4 administration individually had any effect on kidney sulfate transporter mRNA levels, ruling out direct regulation by either steroid. Furthermore, administration of E 2 þ P 4 together did not recapitulate pregnancyinduced sulfate transporter up-regulation but resulted in only a modest increase in renal Slc26a1 mRNA levels. Nonetheless, increased and abundant kidney Slc13a1 and Slc26a1 mRNA expression in early gestation may provide a physiological mechanism for increased renal sulfate reabsorption that leads to high maternal sulfatemia in mouse pregnancy. The potential contribution of kidney SLC13A1 and SLC26A1 sulfate transporters to increased sulfatemia in human gestation awaits further investigation.
Of great interest is the obligate requirement for sulfate supply from mother to fetus via placental sulfate transporters. Whilst maternal hyposulfatemia and loss of placental estrogen sulfotransferase are linked to midgestational fetal loss in mice [15, 16] , the relative contribution of placental sulfate transporters to fetal sulfate supply and pregnancy outcomes has not been investigated. As an approach to determine the vectorial transport of sulfate in the placenta, we determined the temporal expression profile, relative abundance, and spatial expression of all known sulfate transporters from E6.5 to E18.5 in mouse gestation. Slc13a4 and Slc26a6 mRNA expression in the yolk sac suggests that these two transporters may be 
FIG. 5.
Slc13a4 is expressed in syncytiotrophoblast layer-II, and Slc26a2 is expressed in synctyiotrophoblast layer-I. Slc13a4 (A) and Slc26a2 (B) expression are restricted to the labyrinthine layer (E14.5). C) Slc13a4 staining (blue; black arrow) is localized to the maternal side of isolectin B4 staining (brown; white arrow). D) Slc26a2 staining (blue; black arrow) is localized to the maternal side of isolectin B4 staining (brown; white arrow). E) Slc13a4 staining (brown; white arrow) does not colocalize with Syna staining (blue; black arrow) and is more proximal to fetal blood spaces. Neither Slc13a4 nor Slc26a2 expression is apparent in the sinusoidal trophoblast giant cells lining the maternal blood spaces (asterisk), confirming syncytiotrophoblast-specific expression. F) Slc26a2 staining (blue; black arrow) does not colocalize with Slc13a4 staining (brown; white arrow) and is more proximal to maternal blood spaces. G) Slc13a4 expression is localized to clusters of cells at the leading edge of the chorion in E8.5 placentae. H) Gcm1 expression is localized to clusters of cells at the leading edge of the chorion in E8.5 placentae. Mbs, maternal blood space; fbs, fetal blood space. Original magnification 31.5 (filled bar, 0.67 lm), 320 (gray bar, 50 nm), and 340 (unfilled bar, 25 nm).
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mediating sulfate supply to the developing embryo in early gestation. Slc26a6 null mice appear normal at birth and during the postnatal period [39] , confirming that yolk sac Slc26a6 expression is not essential for early embryonic development. Strong Slc13a4 mRNA expression in the yolk sac indicates that this transporter may be mediating sulfate supply to the developing embryo prior to chorioallantoic placental attachment from E8.5. In addition, Slc13a4 is the most abundant placental sulfate transporter mRNA and is localized to the SynT-II cells of the labyrinth, where sulfate transport from maternal circulation occurs (Fig. 6) . Together, these findings indicate that Slc13a4 is most likely to play an important role in sulfate supply to the fetus and warrants future studies of Slc13a4 in mouse and human gestation.
We also measured abundant levels of Slc26a2 mRNA, which was localized to SynT-I cells in the labyrinth. SynT-I cells are located between the sinusoidal trophobast giant cells (S-TGCs) that line the maternal blood sinusoids and the SynT-II cell layer (Fig. 6) , although SynT-I cells still have direct access to maternal blood because of the numerous fenestrations in the S-TGCs [40] . Therefore, these cells represent the likely entry point for maternal sulfate crossing the feto-maternal barrier. SLC26A2 has been linked to chondrodysplasias in humans (reviewed in Dawson and Markovich [10] ) and mice [41] , with the most severe phenotype being achondrogenesis type IB (ACG1B), which results in skeletal underdevelopment and death in utero or shortly after birth [42] . While the etiology of SLC26A2 phenotypes has focused on reduced sulfate transport into fetal chondrocytes, the involvement of SLC26A2 in reduced placental sulfate transport that could lead to fetal hyposulfatemia and potentially exacerbate skeletal phenotypes has not been considered.
In late gestation, we detected abundant levels of Slc26a1 mRNA in spongiotrophoblasts. Previously, we showed enlargement of the spongiotrophoblast layer in placentae from maternal hyposulfatemic Slc13a1 null mice, possibly to compensate for a low supply of sulfate from maternal circulation. Spongiotrophoblasts produce numerous endocrine-active proteins that are important for maintenance of pregnancy and fetal development [43] [44] [45] [46] . The physiological role of Slc26a1 mRNA expression in spongiotrophoblast cells is not known; however, Slc26a1 null mice appear normal at birth and through adulthood [21] , indicating that Slc26a1 mRNA expression in spongiotrophoblasts is not essential for fetal growth and development.
In summary, this is the first study to determine the relative abundance and temporal profile of all known kidney, ileal, and placental sulfate transporters during mouse gestation. We show increased and abundant kidney Slc13a1 and Slc26a1 mRNA in early mouse gestation, suggesting their role in increasing sulfatemia during pregnancy. In addition, we identified abundant expression of Slc13a4 in yolk sac and SynT-II cells and Slc26a2 in SynT-I cells, suggesting an important role of Slc13a4 and Slc26a2 in the vectorial supply of sulfate from mother to fetus in both early and late gestation. These findings prompt future studies of sulfate transporters in humans with altered sulfate homeostasis in pregnancy.
